Muneto Mogi
32Patents
5h-index
107Co-inventors
72Inventor score
Filing activity: Apr 17, 2001 → Feb 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8129411B2 | Organic compounds | Chemistry; Metallurgy | 36 | Active |
| US6911443B2 | Imidazopyrimidine derivatives and triazolopyrimidine derivatives | Human Necessities | 28 | Expired |
| US8263629B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | Chemistry; Metallurgy | 18 | Active |
| US8394853B2 | Substituted aminopropionic derivatives as neprilysin inhibitors | Chemistry; Metallurgy | 11 | Active |
| US8222286B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | Chemistry; Metallurgy | 7 | Active |
| US7615557B2 | Tetrahydro-naphthalene and urea derivatives | Chemistry; Metallurgy | 5 | Expired |
| US8377978B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9006249B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | Chemistry; Metallurgy | 3 | Active |
| US7381840B2 | Tetrahydro-naphthalene derivatives | Chemistry; Metallurgy | 3 | Expired |
| US7423175B2 | Hydroxy-tetrahydro-naphthalenylurea derivatives | Chemistry; Metallurgy | 2 | Expired |
| US7612113B2 | Hydroxy tetrahydro-naphthalenylurea derivatives | Chemistry; Metallurgy | 2 | Expired |
| US7544716B2 | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists | Chemistry; Metallurgy | 2 | Expired |
| US10537563B2 | Methods for treating ocular disease using inhibitors of CSF-1R | Human Necessities | 1 | Active |
| US8642635B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11478480B2 | Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile | Human Necessities | 1 | Active |
| US9957254B2 | Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators | Chemistry; Metallurgy | 0 | Active |
| US12290517B2 | Formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile | Human Necessities | 0 | Active |
| US8759365B2 | Organic compounds | Chemistry; Metallurgy | 0 | Active |
| US8088826B2 | Tetrahydro-naphthalene derivatives | Chemistry; Metallurgy | 0 | Active |
| US12129246B1 | Hydroquinazoline derivatives for the treatment of a disease or disorder | Chemistry; Metallurgy | 0 | Active |
| US8877815B2 | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP | Chemistry; Metallurgy | 0 | Active |
| US8193349B2 | 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11234982B2 | Methods for treating ocular surface pain | Human Necessities | 0 | Active |
| US8440682B2 | 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9603819B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.